5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Reference: new trials by email Literature Review of Reference trials Research Report on Reference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population LAS100977, Reference, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Completed | AstraZeneca | 87 | 2011-08-01 | 2017-04-10 |
| Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test LAS41004, reference - Psoriasis | Phase 2 | Completed | Almirall, S.A. | 22 | 2011-05-01 | 2015-06-08 |
| Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis Experimental: LAS 41004 dosage 1, Experimental: LAS 41004 dosage 2, Experimental: LAS 41004 dosage 3 - Psoriasis | Phase 2 | Completed | Almirall, S.A. | 20 | 2011-01-01 | 2015-05-29 |
| Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis LAS 41004, LAS 41004 dosage 6, Placebo - Psoriasis | Phase 2 | Completed | Almirall, S.A. | 20 | 2010-07-01 | 2015-05-29 |
| Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery Ropivacaine, Reference - Postoperative Pain, Cancer | Phase 2 | Completed | Institut Bergonié | 90 | 2003-10-01 | 2025-09-08 |
Psoriasis (3) · Ceroid lipofuscinosis, neuronal 1, infantile (1) · Neoplasms (1) · Pain, Postoperative (1) · Pulmonary Disease, Chronic Obstructive (1)
Almirall, S.A. (3) · AstraZeneca (1) · Institut Bergonié (1)
Germany (4) · France (1)
Christoph Willers, MD, MBA (2) · Carol Astbury, PhD (1) · Christoph Willers, MD (1)